Remdesivir and clinical improvement in hospitalized patients with COVID-19
(JAMA Network) This comparative effectiveness research study that included a high proportion of non-White individuals assesses whether remdesivir administered alone or with corticosteroids is associated with time to clinical improvement or time to death in patients hospitalized with confirmed COVID-19. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 24, 2021 Category: International Medicine & Public Health Source Type: news

Corticosteroids in COVID-19: Should It Be Standard-of-Care? Corticosteroids in COVID-19: Should It Be Standard-of-Care?
Corticosteroids have provided a useful treatment option for COVID-19, but the benefits and drawbacks of this therapy should be considered.Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 17, 2021 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Checkpoint Inhibitor Rheumatic Complications Often Arise Late Checkpoint Inhibitor Rheumatic Complications Often Arise Late
Most checkpoint inhibitor-induced rheumatic complications in patients with cancer can be treated successfully with corticosteroids, albeit often at considerably higher doses than rheumatologists typically use in managing rheumatoid arthritis, says an expert.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 16, 2021 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Disentangling the complex bidirectional associations between COVID-19 and psychiatric disorder, Lancet Psychiatry
In The Lancet Psychiatry, Maxime Taquet and colleagues reported that survivors of COVID-19 appear to be at increased risk of psychiatric sequelae, and that a psychiatric diagnosis might be an independent risk factor for COVID-19. We are concerned that several limitations might weaken the bidirectional associations between COVID-19 and psychiatric disorder. First, evidence suggests that the medical isolation of hospitalised patients might have a negative effect on their mental wellbeing and behaviour, with higher levels of depression and anxiety among isolated patients.Therefore, the psychiatric sequelae of COVID-19 might r...
Source: Current Awareness Service for Health (CASH) - March 3, 2021 Category: Consumer Health News Source Type: news

Transplant patients may not need steroid treatment in the long run
(University of Cincinnati) Corticosteroids in kidney transplant patients may not be needed past a seven-day post surgery period, according to a University of Cincinnati College of Medicine study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 24, 2021 Category: International Medicine & Public Health Source Type: news

Epidural Steroids and Infection Risk After Spine Surgery Epidural Steroids and Infection Risk After Spine Surgery
A new study examines the question of whether preoperative lumbar epidural corticosteroid injections are associated with an increased risk for infection after spinal surgery. Is there a link?Spine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 18, 2021 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

Effectiveness of corticosteroids in patients with sepsis or septic shock using the new third international consensus definitions (Sepsis-3): A retrospective observational study, PLoS One 15(12): e0243149
Conclusions: In patients with sepsis or septic shock, intravenous corticosteroids were not associated with a higher in-hospital survival up to 50 days regardless of the sepsis definitions. Further research may be necessary to definitively confirm effectiveness in real-world practice. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 11, 2021 Category: Consumer Health News Source Type: news

Janssen Announces Treatment with ERLEADA ® (apalutamide) Significantly Improved Overall Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer
RARITAN, N.J., February 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the final analysis of the Phase 3 TITAN study, which demonstrated the continued statistically significant benefit of the addition of ERLEADA® (apalutamide) to androgen deprivation therapy (ADT) in overall survival (OS) in patients with metastatic castration-sensitive prostate cancer (mCSPC), regardless of extent of disease, when compared to placebo plus ADT.[1] Results will be featured in an oral presentation at the American Society of Clinical Oncology’s Genitourinary (ASCO GU) Cance...
Source: Johnson and Johnson - February 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Presents Results from Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA ® (apalutamide) and ZYTIGA® (abiraterone acetate) Combination
RARITAN, N.J., February 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the randomized, double-blind, placebo-controlled Phase 3 ACIS study, which met the primary endpoint of radiographic progression-free survival (rPFS) with a 31 percent reduction in the risk of radiographic progression or death in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) receiving androgen deprivation therapy (ADT). Patients in the trial received either a combination of ERLEADA® and ZYTIGA® plus prednisone (combination arm) or placebo a...
Source: Johnson and Johnson - February 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU
February 2, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it will highlight the depth of its solid tumor portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium with 12 data presentations, including three company-sponsored oral presentations from the ERLEADA® (apalutamide) clinical development program. The virtual meeting will take place February 11-13, 2021. “We are committed to the development of innovative therapies for patients with genitourinary cancers for whom there remains a high unmet need,” said C...
Source: Johnson and Johnson - February 2, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Podcast: What are the benefits and risks of giving corticosteroids to pregnant women at risk of premature birth?
Monday, February 1, 2021 (Source: Cochrane News and Events)
Source: Cochrane News and Events - February 1, 2021 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Corticosteroid Therapy for COVID-19-Related ARDS Corticosteroid Therapy for COVID-19-Related ARDS
What role do corticosteroids have in the treatment of ARDS caused by COVID-19? How might this therapy impact the risk of in-hospital mortality in these patients?Critical Care (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 19, 2021 Category: Intensive Care Tags: Critical Care Journal Article Source Type: news

Corticosteroid Therapy for COVID-19-Related ARDS Corticosteroid Therapy for COVID-19-Related ARDS
What role do corticosteroids have in the treatment of ARDS caused by COVID-19? How might this therapy impact the risk of in-hospital mortality in these patients?Critical Care (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 19, 2021 Category: Consumer Health News Tags: Critical Care Journal Article Source Type: news

DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
January 15, 2021 (HORSHAM, Pa.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis.[1] DARZALEX FASPRO® is the first and only FDA-approved treatment for patients with this blood cell disorder that is associated with the production of an abnormal protein, which leads to th...
Source: Johnson and Johnson - January 16, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma
THOUSAND OAKS, Calif., Dec. 21, 2020 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced the SOURCE trial did not meet the primary endpoint of a statistically significant reduction in the daily oral corticoster... Biopharmaceuticals Amgen, AstraZeneca, tezepelumab, asthma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 22, 2020 Category: Pharmaceuticals Source Type: news

Position statement: Use of investigational immunomodulatory medicines for COVID-19 Interim support for UK hospital clinicians, RCP
Key messages • A subset of patients with COVID-19 may experience an exaggerated hyperinflammatory response • COVID-19 associated hyperinflammation predominantly involves the lung however may progress to secondary haemophagocytic lymphohistocytosis (sHLH) which is a systemic and multi-organ condition with significant morbidity and mortality • CTAG strongly recommends systemic corticosteroids for patients who fit definitions of WHOdefined severe or critical COVID-19, or in patients who otherwise have a new oxygen requirement • CTAG also recommends not to use corticosteroid therapy in patients with...
Source: Current Awareness Service for Health (CASH) - December 21, 2020 Category: Consumer Health News Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Patient Care - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Administration and Leadership - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Latest News - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS: Journal of Emergency Medical Services News - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Operations - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Special Topics - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Extraction with an electric motor-driven handpiece may still cause subcutaneous emphysema - A case report
This article reported a case of SE around the paraorbital and submandibular regions through extractions of teeth 28 and 38. This 20-year-old man came to the emergency room at night with the major complaint of pain and discomfort during swallowing. Sudden swelling at his left face during extractions of teeth 28 and 38 three hours ago was mentioned. The original surgeon who performed the odontectomy was aware of the SE after removing the surgical drape and specific post-operation instructions were given as follows: immediate hospital care may be needed if the patient encountered difficulties in swallowing or any worsen compl...
Source: Dental Technology Blog - December 14, 2020 Category: Dentistry Source Type: news

Featured Review: Antenatal corticosteroids for accelerating fetal lung maturation in women at risk of preterm birth
The Cochrane review aboutantenatal steroids in reducing risk of infant mortality and morbidity is animportant one inCochrane's history. Cochrane's logo is based on the forest plot from the original  publication in 1982. This review has recently been updated and lead author, Fiona Stewart, tells us how the logo might look now, base on the current data.What does this update tell us?  Our overall findings can be summed up like this: antenatal steroids given to women at risk of preterm birth reduce the risk of infant mortality and morbidity. In other words, babies are more likely to survive and less likely to ha...
Source: Cochrane News and Events - December 10, 2020 Category: Information Technology Authors: Katie Abbotts Source Type: news

Clinical guide during the COVID-19 pandemic for the management of patients with musculoskeletal and rheumatic conditions who are using corticosteroids, British Society of Rheumatology
This update makes recommendations on management of patients with musculoskeletal and rheumatic conditions who are already taking or require initiation of corticosteroids, or require a corticosteroid injection in the context of the COVID-19 pandemic. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 3, 2020 Category: Consumer Health News Source Type: news

Management of patients with musculoskeletal and rheumatic conditions
An update to the clinical guide for the management of patients with musculoskeletal and rheumatic conditions who are already taking corticosteroids, or require initiation of oral/IV corticosteroids, or require a corticosteroid injection in the context of the COVID-19 pandemic has been published on the British Society of Rheumatology website. (Source: NHS Networks)
Source: NHS Networks - December 2, 2020 Category: UK Health Source Type: news

' Clear Evidence' Oral Steroid Effective for'Suicide Headache'' Clear Evidence' Oral Steroid Effective for'Suicide Headache '
A new study provides the first"clear evidence" that oral corticosteroids significantly reduce attacks for patients with cluster headache.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - December 1, 2020 Category: Emergency Medicine Tags: Neurology & Neurosurgery News Source Type: news

FDA approves Xolair ® (omalizumab) for adults with nasal polyps
             Basel, 01 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) for the add-on maintenance treatment of nasal polyps in adult patients 18 years of age and older with inadequate response to nasal corticosteroids.1 Nasal polyps can lead to a loss of smell and nasal congestion, and frequently co-occur with other respiratory conditions, such as allergies and asthma. With this ap...
Source: Roche Media News - December 1, 2020 Category: Pharmaceuticals Source Type: news

FDA approves Xolair ® (omalizumab) for adults with nasal polyps
             Basel, 01 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) for the add-on maintenance treatment of nasal polyps in adult patients 18 years of age and older with inadequate response to nasal corticosteroids.1 Nasal polyps can lead to a loss of smell and nasal congestion, and frequently co-occur with other respiratory conditions, such as allergies and asthma. With this ap...
Source: Roche Investor Update - December 1, 2020 Category: Pharmaceuticals Source Type: news

Therapeutics and COVID-19: living guideline, WHO
Recommendations: The panel made a conditional recommendation against the use of remdesivir in hospitalized patients with COVID-19, regardless of disease severity. This guidance adds to recommendations published in the previous version: a strong recommendation for systemic corticosteroids in patients with severe and critical COVID-19, and a conditional recommendation against systemic corticosteroids in patients with non-severe COVID-19. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 30, 2020 Category: Consumer Health News Source Type: news

Epidural Corticosteroid Injections for Sciatica Epidural Corticosteroid Injections for Sciatica
Does recent evidence support the use of epidural corticosteroid injections as a safe and effective option for sciatica?Spine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 26, 2020 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

Immune checkpoint inhibitor efficacy against glioblastoma may decrease with dexamethasone
(American Association for Cancer Research) Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline for cerebral edema had significantly worse overall survival. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 25, 2020 Category: International Medicine & Public Health Source Type: news

Improvements in Chronic Hand Eczema Seen With Oral Gusacitinib Improvements in Chronic Hand Eczema Seen With Oral Gusacitinib
Gusacitinib, a novel oral inhibitor of multiple inflammatory pathways, achieved rapid and clinically meaningful improvement in corticosteroid-refractory moderate to severe chronic hand eczema.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 23, 2020 Category: Consumer Health News Tags: Dermatology News Source Type: news

COVID-19 therapy: corticosteroids including dexamethasone and hydrocortisone
In accordance with World Health Organization (WHO) recommendations, systemic corticosteroids should be used in patients with severe and critical COVID-19 disease, but not in patients with non-severe C (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 20, 2020 Category: Drugs & Pharmacology Source Type: news

COVID-19 therapy: corticosteroids including dexamethasone and hydrocortisone, NHS England
In accordance with World Health Organization (WHO) recommendations, this letter explains that systemic corticosteroids should be used in patients with severe and critical COVID-19 disease, but not in patients with non-severe COVID-19. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 17, 2020 Category: Consumer Health News Source Type: news

ACR: Corticosteroid Injections Do Not Speed Progression of Knee OA
FRIDAY, Nov. 13, 2020 -- For patients with knee osteoarthritis (OA), corticosteroid injections (CSIs) do not speed progression compared with hyaluronic acid injections (HAI), according to a study presented at ACR Convergence, the annual meeting of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2020 Category: Pharmaceuticals Source Type: news

Methotrexate Users Need Tuberculosis Tests in High-TB Areas Methotrexate Users Need Tuberculosis Tests in High-TB Areas
Those taking corticosteroids or other immunosuppressants are at particularly high risk, a systematic review of literature finds.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2020 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Janssen Headlines American Society of Hematology Annual Meeting With More Than 35 Presentations Highlighting Deep, Diverse Oncology Pipeline and Portfolio
RARITAN, N.J., November 5, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today more than 35 company-sponsored studies, including 10 oral presentations, will be featured at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition taking place virtually December 5-8, 2020.In multiple myeloma, highlights include Phase 1b/2 results for the B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CAR-T) therapy ciltacabtagene autoleucel (cilta-cel); new and updated data for the anti-CD38 monoclonal antibody DARZALEX® (daratumumab) and the subcutane...
Source: Johnson and Johnson - November 5, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Corticosteroids Improve Histologic Response Rates in Pediatric Eosinophilic Esophagitis Corticosteroids Improve Histologic Response Rates in Pediatric Eosinophilic Esophagitis
Corticosteroids significantly improve histologic response rates in children with eosinophilic esophagitis (EoE), according to a new meta-analysis.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 29, 2020 Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news

Study Shows Baricitinib Reduces Adult Atopic Dermatitis Severity Study Shows Baricitinib Reduces Adult Atopic Dermatitis Severity
Signs and symptoms of moderate to severe atopic dermatitis were significantly reduced with baricitinib 4 mg on top of topical corticosteroids, compared with placebo in the phase 3, BREEZE-AD7 study.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 26, 2020 Category: Dermatology Tags: Dermatology News Source Type: news

Could Common Asthma Meds Weaken Bones?
THURSDAY, Oct. 22, 2020 -- People who use common asthma controller medications are vulnerable to developing brittle bones and suffering fractures, a new study shows. The findings point the finger at anti-inflammatory corticosteroids -- whether... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 22, 2020 Category: General Medicine Source Type: news

Corticosteroid Exposure Affects Bone Health in Asthma Patients
Oral, inhaled corticosteroid use linked to increased risk for osteoporosis, fragility fractures (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 21, 2020 Category: Respiratory Medicine Tags: Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Allergy, Orthopedics, Pharmacy, Pulmonology, Rheumatology, Journal, Source Type: news

Immune-Modulating Agents, Royal College of Physicians
Key message A subset of patients with COVID-19 may experience an exaggerated hyperinflammatory response COVID-19 associated hyperinflammation predominantly involves the lung however may progress to secondary haemophagocytic lymphohistocytosis (sHLH) which is a systemic and multi-organ condition with significant morbidity and mortality CTAG strongly recommends systemic corticosteroids for patients who fit definitions of WHO-defined severe or critical COVID-19, or in patients who otherwise have a new oxygen requirement CTAG also recommends not to use corticosteroid therapy i n patients with WHO-defined non-severe...
Source: Current Awareness Service for Health (CASH) - October 21, 2020 Category: Consumer Health News Source Type: news

Corticosteroid and remdesivir eligibility criteria, Royal College of Physicians
Flowchart to show path for management of hospitalised adults with proven or suspected Covid-19. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 21, 2020 Category: Consumer Health News Source Type: news

Corticosteroid Exposure Affects Bone Health in Asthma Patients
WEDNESDAY, Oct. 21, 2020 -- For patients with asthma, oral corticosteroid (OCS) and inhaled corticosteroid (ICS) use is associated with an increased risk for osteoporosis and fragility fractures (FFs), according to a study published online Oct. 20... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 21, 2020 Category: Pharmaceuticals Source Type: news

Scientists throw old drugs and new into fight against Covid
Corticosteroids have proved their worth. Monoclonal antibodies may be next (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - October 19, 2020 Category: Pharmaceuticals Source Type: news

Don't Discount Ultrapotent Topical Corticosteroids for Vulvar Lichen Sclerosus Don't Discount Ultrapotent Topical Corticosteroids for Vulvar Lichen Sclerosus
Still,"there is no question, there is no argument: First-, second- and third-line treatment for lichen sclerosus is an ultrapotent or superpotent topical corticosteroid."Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2020 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Steroids Don't Reduce Mortality in COVID-19 Patients With COPD Steroids Don't Reduce Mortality in COVID-19 Patients With COPD
Inhaled corticosteroids do not protect patients with chronic respiratory conditions against COVID-19-related death.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 12, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Dexamethasone: Here Are The Side Effects Of The Covid-19 Coronavirus Treatment That Trump Received
In addition to physical side effects, corticosteroids can affect your mood, thinking, and behavior. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 7, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news